GLP-1 Receptor Agonist Market On the other hand, the Canadian government is initiating plans, including Canada's Diabetes 360, aimed at minimizing diabetes prevalence, with funding allocated to novel treatment choices like GLP-1 receptor agonists
#1 Re-positioning existing SKUs as companion products for consumers on GLP-1 drugs, from gut health products to counter unpleasant GI side effects to supplements to mitigate nutrient gaps caused by reduced food intake
The way it works is that microscopic needles deliver a steady stream of medicineequivalent to a once-daily injectable doseinto the bloodstream or into the dermal fluid, she explains
For example, individuals preparing for bariatric surgery may benefit from GLP-1 or tirzepatide based therapies that reduce liver size and improve surgical safety
Tirzepatide for the treatment of adults with type 2 diabetes: an endocrine perspective
Evaluation of the safety of drugs and biological products used during lactation: workshop summary
